Ideaya Biosciences Inc (IDYA) Company Profile & Statistics

Ideaya Biosciences Inc
IDYA
(Nasdaq - US)
Closed
26.62
-2.85 (-9.69%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
29.33
High
29.79
Low
26.42

About Ideaya Biosciences Inc

CEO

Yujiro Hata

Headquarters

7000 shoreline court, suite 350

south san francisco, ca 94080, united states

Auditor

PricewaterhouseCoopers LLP

Employees

124

Share Holders

Website

www.ideayabio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

IDEAYA Biosciences Inc. is an oncology-focused precision medicine company. It focuses on the discovery and development of therapeutics for patients using molecular diagnostics. The company's product pipeline consists of IDE196, MAT2A, PARG, Pol-theta and WRN which are in clinical stage. IDEAYA Biosciences Inc. is based in South San Francisco, United States.

Ideaya Biosciences Inc Statistics

Valuation Measures

Market Capitalization ²	2.30B
Enterprise Value	2.12B
Enterprise Value/EBITDA (ttm)	-10.12
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.95
Price to Sales (ttm)	98.46
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	50.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-301.73%
Return on Equity (ttm)	-19.42%
Return on Invested Capital (ttm)	-20.76%
Return on Assets (ttm)	-18.63%

Income Statement

Revenue (ttm)	11.96M
Revenue Per Share (ttm)	0.14
Gross Profit (ttm)	11.96M
EBITDA (ttm)³	-209.27M
Net Income Avi to Common (ttm)	-153.74M
Diluted EPS (ttm)	-2.33

Share Statistics

Beta (5Y Monthly)	0.86
52-Week Change	-13.64%
S&P500 52-Week Change	29.10%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	84.48M
Dividend Yield	0.00%
Float ⁴	83.41M
% Held by Insiders	3.50%
% Held by Institutions	98.29%

Balance Sheet

Total Cash (mrq)	701.66M
Total Cash Per Share (mrq)	8.31
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	17.50%
Quick Ratio (mrq)	22.93%
Book Value Per Share (mrq)	12.24

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.98
Free Cash Flow (ytd)	-78.99M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Ideaya Biosciences Inc

Trade With A Regulated Broker